E-Cigs As Medicines: Why Proposed EU Classification Will Not Work
April 21, 2013
We’ve been talking on the VIP blog a lot about the proposed changes to EU regulations concerning electronic cigarettes and it’s not because we’ve run out of things to talk about – it’s because the issue is massively important both to a fantastic industry that’s really starting to make significant growth, particularly in the UK, as well as smokers who are looking for a healthier alternative to tobacco and want to change their lives for the better.
Here at VIP Electronic Cigarette we work closely with ECITA, the industry’s trade association, who have recently visited Brussels to state the case for why the new proposals will do more harm than good, and simply won’t work. A lot has been made of the move to class e-cigs as medicines, as much of the regulation’s downfall is based around this proposed classification – and we run down why this simply won’t work.
posted in Electronic Cigarette News
Combating The Negatives: Now Is Crucial Time For Positive Press
April 14, 2013
One thing that both e-cig sceptics and businesses agree on is the necessity, to some degree, of regulation. It’s something we here at VIP have spoken about extensively, both here on our blog and in media interviews, suggesting that quality control and assurances that electronic cigarette products are restricted to adults are essential.
But where there is disparity between both sides’ views on regulation is just how much – defenders of the industry, such as renowned commentator Clive Bates, express concerns that regulating electronic cigarettes as medicines because they contain nicotine could kill the industry through expensive and time consuming testing and hoop-jumping.
posted in Electronic Cigarette News
ECITA Representative Visit Brussels To Defend E-Cigs In EU Proposals
March 22, 2013
We’ve already talked about the new EU directive here at VIP in a previous blog post which, if implemented in the way it’s been proposed, could threaten the electronic cigarette industry with unnecessary regulations, time consuming approval processes and expensive medical research.
Effectively, the proposal seeks to classify any products containing nicotine over 0.4% as medicinal product. What this means for the electronic cigarette industry, which consists chiefly of small and medium enterprises, is a seemingly endless set of regulatory hoops to jump through which cost money an industry in its infancy can ill afford.
posted in Electronic Cigarette News
